{"id":28050,"date":"2014-08-12T11:19:07","date_gmt":"2014-08-12T15:19:07","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=28050"},"modified":"2014-08-12T11:19:07","modified_gmt":"2014-08-12T15:19:07","slug":"intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050","title":{"rendered":"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 A biopharmaceutical company, <b>Intercept Pharmaceuticals Inc (NASDAQ:ICPT)<\/b> shares were climbing over 60% in the pre-market trading activities on Tuesday after the company disclosed on Monday after the market closed that its liver drug was <a href=\"http:\/\/finance.yahoo.com\/news\/intercepts-liver-drug-found-effective-230843052.html\" target=\"_blank\">effective<\/a> during the mid-stage trials.<\/p>\n<p style=\"text-align: justify;\"><b>Liver Drug<\/b><\/p>\n<p style=\"text-align: justify;\">Intercept Pharmaceuticals Inc (NASDAQ:ICPT)\u00a0had indicated that obeticholic acid, a drug, was tested in patients, who were non-alcoholic steatohepatitis or NASH, which was known as a liver inflammation form. Currently, there does not appear to be any approved treatment for this.<\/p>\n<p style=\"text-align: justify;\">Intercept Pharmaceuticals said that it had given the drug to 46% of NASH patients, and they did not find any worsening of liver scarring compared to the 21% in the placebo group. After the drug had shown significant statistical improvements in patients, it had stopped the trial on January 9.<\/p>\n<p style=\"text-align: justify;\"><b>Drug Safety<\/b><\/p>\n<p style=\"text-align: justify;\">Though the shares of the company jumped significantly after it disclosed the news, the gains were vanished in the following months since investors were more concerned about the side-effects of the drug and preferred to wait for a full clinical trial result.<\/p>\n<p style=\"text-align: justify;\">Oppenheimer analyst Akiva Felt had reportedly told <a href=\"http:\/\/finance.yahoo.com\/news\/intercepts-liver-drug-found-effective-230843052.html\" target=\"_blank\">Reuters<\/a> that the fear among the investors on the safety of the drug has now been put to rest as a result of the latest update from the company. He felt that the trial results were undoubtedly a positive new development.<\/p>\n<p style=\"text-align: justify;\">Intercept Pharmaceuticals Inc (NASDAQ:ICPT)\u00a0had indicated that it intends to commence late-stage study of the drug during the first half of the <a href=\"http:\/\/finance.yahoo.com\/news\/intercept-pharmaceuticals-reports-second-quarter-201533594.html\" target=\"_blank\">next<\/a> year. The drug is also tested for primary biliary cirrhosis treatment.<\/p>\n<p style=\"text-align: justify;\"><b>Share Price<\/b><\/p>\n<p style=\"text-align: justify;\">Shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT)\u00a0closed Monday\u2019s regular trading at $237.18 gaining $2.58 or 1.10% during the regular trading session. The stock started surging in the extended hours of trading on Monday after the company announced its financial results and the positive data on liver drug after the market closed. It had climbed as big as 65%, which was undoubtedly a big thing considering the stock price of $235+. Both in terms of percentage and the value, it was a big gain. The trend continued in the pre-market trading activities too.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 A biopharmaceutical company, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares were climbing over 60% in the pre-market trading activities on Tuesday after [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":28074,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7844,7845],"stock_ticker":[],"class_list":["post-28050","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-intercept-pharmaceuticals-inc-nasdaqicpt","tag-nasdaqicpt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 A biopharmaceutical company, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares were climbing over 60% in the pre-market trading activities on Tuesday after [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-12T15:19:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug\",\"datePublished\":\"2014-08-12T15:19:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\"},\"wordCount\":364,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg\",\"keywords\":[\"Intercept Pharmaceuticals Inc (NASDAQ:ICPT)\",\"NASDAQ:ICPT\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\",\"name\":\"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg\",\"datePublished\":\"2014-08-12T15:19:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050","og_locale":"en_US","og_type":"article","og_title":"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug - Wall Street PR","og_description":"Boston, MA 08\/12\/2014 (wallstreetpr) \u2013 A biopharmaceutical company, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares were climbing over 60% in the pre-market trading activities on Tuesday after [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-12T15:19:07+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug","datePublished":"2014-08-12T15:19:07+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050"},"wordCount":364,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg","keywords":["Intercept Pharmaceuticals Inc (NASDAQ:ICPT)","NASDAQ:ICPT"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050","url":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050","name":"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg","datePublished":"2014-08-12T15:19:07+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Intercept-Pharmaceuticals.jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/intercept-pharmaceuticals-inc-nasdaqicpt-shares-surge-on-favorable-news-on-liver-drug-28050#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Shares Surge On Favorable News On Liver Drug"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=28050"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28050\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/28074"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=28050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=28050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=28050"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=28050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}